• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国孕产妇静脉血栓栓塞症的发生率:一项系统评价和荟萃分析。

Incidence of maternal venous thromboembolism in China: A systematic review and meta-analysis.

机构信息

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of the Ministry of Education of Birth Defects and Related Maternal and Child Diseases, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Int J Gynaecol Obstet. 2023 Oct;163(1):75-88. doi: 10.1002/ijgo.14776. Epub 2023 Apr 17.

DOI:10.1002/ijgo.14776
PMID:37069776
Abstract

BACKGROUND

Venous thromboembolism (VTE) is one of the primary causes of maternal death. Although many studies have reported maternal VTE, no study has estimated the incidence of it in China.

OBJECTIVES

The aim of this work was to estimate the incidence of maternal VTE in China and to compare the risk factors for it.

SEARCH STRATEGY

The authors searched eight platforms and databases including PubMed, Embase, and Cochrane Library from inception to April 2022, with the search terms "venous thromboembolism" AND "puerperium (pregnancy)" AND "incidence" AND "China."

SELECTION CRITERIA

Studies provide data to calculate the incidence of maternal VTE among Chinese patients.

DATA COLLECTION AND ANALYSIS

The authors made a standardized table to collect data and calculated the incidence and 95% confidence intervals (CIs), founding source of heterogeneity by subgroup analysis and meta-regression and judging publication bias by funnel plot and Egger test.

MAIN RESULTS

The included 53 papers with a total sample size of 3 813 871 patients had 2539 cases of VTE, and the incidence of maternal VTE in China was 0.13% (95% CI, 0.11-0.16; P < 0.001).

CONCLUSIONS

The trend in the incidence of maternal VTE in China is stable. Cesarean section and advanced age are associated with a higher incidence of VTE.

摘要

背景

静脉血栓栓塞症(VTE)是导致产妇死亡的主要原因之一。尽管有许多研究报告了产妇 VTE,但没有研究估计中国的 VTE 发病率。

目的

本研究旨在估计中国产妇 VTE 的发病率,并比较其危险因素。

检索策略

作者检索了从建库至 2022 年 4 月的 8 个平台和数据库,包括 PubMed、Embase 和 Cochrane Library,检索词为“venous thromboembolism”AND“puerperium (pregnancy)”AND“incidence”AND“China”。

选择标准

研究提供了数据来计算中国患者中产妇 VTE 的发病率。

数据收集和分析

作者制作了一个标准化表格来收集数据,并计算发病率和 95%置信区间(CI),通过亚组分析和荟萃回归发现异质性来源,并通过漏斗图和 Egger 检验判断发表偏倚。

主要结果

纳入的 53 篇文献共有 3813871 例患者,其中 2539 例发生 VTE,中国产妇 VTE 的发病率为 0.13%(95%CI,0.11-0.16;P<0.001)。

结论

中国产妇 VTE 的发病率呈稳定趋势。剖宫产和高龄与 VTE 发生率升高相关。

相似文献

1
Incidence of maternal venous thromboembolism in China: A systematic review and meta-analysis.中国孕产妇静脉血栓栓塞症的发生率:一项系统评价和荟萃分析。
Int J Gynaecol Obstet. 2023 Oct;163(1):75-88. doi: 10.1002/ijgo.14776. Epub 2023 Apr 17.
2
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.在择期初次髋关节或膝关节置换术或髋部骨折修复中,直接凝血因子Xa抑制剂与低分子量肝素或维生素K拮抗剂用于预防静脉血栓栓塞的比较
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD011762. doi: 10.1002/14651858.CD011762.pub2.
3
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
4
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.预防带隧道式中心静脉导管的儿科癌症患者发生静脉血栓栓塞事件的全身治疗。
Cochrane Database Syst Rev. 2013 Sep 11(9):CD009160. doi: 10.1002/14651858.CD009160.pub2.
5
Pentasaccharides for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的五糖
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
6
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
7
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
8
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.联合间歇性气动腿部压迫和药物预防预防静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD005258. doi: 10.1002/14651858.CD005258.pub4.
9
Warfarin initiation nomograms for venous thromboembolism.静脉血栓栓塞症的华法林起始剂量计算图。
Cochrane Database Syst Rev. 2016 Jan 29;2016(1):CD007699. doi: 10.1002/14651858.CD007699.pub3.
10
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.初发性无诱因静脉血栓栓塞症患者初始口服抗凝治疗后复发性静脉血栓栓塞症的二级预防
Cochrane Database Syst Rev. 2017 Dec 15;12(12):CD011088. doi: 10.1002/14651858.CD011088.pub2.

引用本文的文献

1
Nurses' knowledge, attitudes, and practices regarding deep vein thrombosis and the nursing management.护士关于深静脉血栓形成及护理管理的知识、态度和实践。
Sci Rep. 2025 May 17;15(1):17174. doi: 10.1038/s41598-025-96551-0.
2
A retrospective cohort analysis of plasma TAT level trends and adverse pregnancy outcomes in early pregnancy patients with newly diagnosed VTE.对新诊断为静脉血栓栓塞症(VTE)的早孕患者血浆凝血酶 - 抗凝血酶复合物(TAT)水平趋势及不良妊娠结局的回顾性队列分析。
Thromb J. 2025 May 15;23(1):48. doi: 10.1186/s12959-025-00732-w.
3
Monocyte/macrophage-mediated venous thrombus resolution.
单核细胞/巨噬细胞介导的静脉血栓溶解。
Front Immunol. 2024 Jul 19;15:1429523. doi: 10.3389/fimmu.2024.1429523. eCollection 2024.